Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System

被引:20
|
作者
Wefers, Christina [1 ,2 ]
Duiveman-de Boer, Tjitske [1 ]
Zusterzeel, Petra L. M. [2 ]
Massuger, Leon F. A. G. [2 ]
Fuchs, David [3 ]
Torensma, Ruurd [1 ]
Wheelock, Craig E. [3 ]
de Vries, I. Jolanda M. [1 ]
机构
[1] Radboudumc, Radboud Inst Mol Life Sci, Dept Tumor Immunol, Geert Grootepl Zuid 28, NL-6525 GA Nijmegen, Netherlands
[2] Radboudumc, Dept Obstet & Gynecol, Geert Grootepl 10, NL-6525 GA Nijmegen, Netherlands
[3] Karolinska Inst, Div Physiol Chem 2, Dept Med Biochem & Biophys, Scheeles Vag 2, SE-17177 Stockholm, Sweden
基金
瑞典研究理事会;
关键词
lipid intermediates; paralyzed T cells; modified lipid metabolism; tumor microenvironment; FATTY-ACID CATABOLISM; PPAR-GAMMA AGONISTS; 9-HYDROXYOCTADECADIENOIC ACID; CELL-CYCLE; T-CELLS; MEDIATORS; IL-2; PROLIFERATION; MICROENVIRONMENT; ASSOCIATION;
D O I
10.3390/ijms19010273
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lipid metabolism is altered in several cancer settings leading to different ratios of intermediates. Ovarian cancer is the most lethal gynecological malignancy. Cancer cells disperse in the abdominal space and ascites occurs. T cells obtained from ascites are unable to proliferate after an antigenic stimulus. The proliferation of ascites-derived T cells can be restored after culturing the cells for ten days in normal culture medium. No pathway aberrancies were detected. The acellular fraction of ascites can inhibit the proliferation of autologous as well as allogeneic peripheral blood lymphocytes, indicating the presence of soluble factors that interfere with T cell functionality. Therefore, we analyzed 109 lipid mediators and found differentially regulated lipids in suppressive ascitic fluid compared to normal abdominal fluid. Our study indicates the presence of lipid intermediates in ascites of ovarian cancer patients, which coincidences with T cell dysfunctionality. Since the immune system in the abdominal cavity is compromised, this may explain the high seeding efficiency of disseminated tumor cells. Further research is needed to fully understand the correlation between the various lipids and T cell proliferation, which could lead to new treatment options.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Ovarian cancer and the immune system - The role of targeted therapies
    Turner, Taylor B.
    Buchsbaum, Donald J.
    Straughn, J. Michael, Jr.
    Randall, Troy D.
    Arend, Rebecca C.
    [J]. GYNECOLOGIC ONCOLOGY, 2016, 142 (02) : 349 - 356
  • [22] The importance of vascular immune regulation in the prognosis of women with advanced ovarian cancer
    Chan, JK
    Samoszuk, M
    [J]. GYNECOLOGIC ONCOLOGY, 2006, 100 (03) : 629 - 630
  • [23] Dendritic cell vaccination, immune regulation, and clinical outcomes in ovarian cancer
    Goyne, Hannah E.
    Cannon, Martin J.
    [J]. FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [24] Immune regulation and anti-cancer activity by lipid inflammatory mediators
    Khadge, Saraswoti
    Sharp, John Graham
    McGuire, Timothy R.
    Thiele, Geoffrey M.
    Black, Paul
    DiRusso, Concetta
    Cook, Leah
    Klassen, Lynell W.
    Talmadge, James E.
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 65 : 580 - 592
  • [25] Interrelations of Sphingolipid and Lysophosphatidate Signaling with Immune System in Ovarian Cancer
    Meshcheryakova, Anastasia
    Svoboda, Martin
    Jaritz, Markus
    Mungenast, Felicitas
    Salzmann, Martina
    Pils, Dietmar
    Castillo-Tong, Dan Cacsire
    Hager, Gudrun
    Wolf, Andrea
    Braicu, Elena Ioana
    Sehouli, Jalid
    Lambrechts, Sandrina
    Vergote, Ignace
    Mahner, Sven
    Birner, Peter
    Zimmermann, Philip
    Brindley, David N.
    Heinze, Georg
    Zeillinger, Robert
    Mechtcheriakova, Diana
    [J]. COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2019, 17 : 537 - 560
  • [26] Peritoneal Immune System in Patients with Advance Epithelial Ovarian Cancer
    Wertel, Iwona
    Nowicka, Aldona
    Rogala, Ewelina
    Kotarski, Jan
    [J]. INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2011, 30 (2-3) : 87 - 101
  • [27] Activated immune system in associated with poor prognosis in ovarian cancer
    Marth, C
    Windbichler, G
    Zeimet, AG
    Daxenbichler, G
    Graf, A
    Stummvoll, W
    Fuchs, D
    [J]. 7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, : 247 - 251
  • [28] The importance of vascular immune regulation in the prognosis of women with advanced ovarian cancer.
    Chan, JK
    Magistris, A
    Loizzi, V
    Rutgers, J
    Osann, K
    DiSaia, PJ
    Samoszuk, M
    [J]. JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2004, 11 (02) : 401A - 401A
  • [29] Lipid mediators in immune regulation and resolution
    Gilroy, Derek W.
    Bishop-Bailey, David
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (08) : 1009 - 1023
  • [30] Integrated analysis reveals microRNA mediated immune system regulation in advanced epithelial ovarian cancer associated with clinical prognosis
    Korsunskiy, I.
    Lovecchio, J. L.
    Menzin, A. W.
    Whyte, J. S.
    Dos Santos, L.
    Liang, S.
    Bhuiya, T.
    Mason, C.
    Khalili, H.
    Shih, A.
    Gregersen, P.
    Lee, A.
    [J]. GYNECOLOGIC ONCOLOGY, 2017, 145 : 75 - 75